About
Kardigan is a biotechnology company focused on advancing precision cardiovascular medicine. Based in South San Francisco and Princeton, Kardigan leverages a data-driven, scientific approach to develop innovative drug candidates that address unmet medical needs in heart health, including dilated cardiomyopathy, calcific aortic valve stenosis, and acute severe hypertension. By integrating advanced cardiac biology and therapeutics, Kardigan aims to improve patient outcomes for challenging cardiovascular diseases.
